The Highest Quality CBD Oil

Meticulously sourced.
Thoughtfully produced.
100% organic.
Discover the difference.
October 4, 2018 | by Iolanda Bulgaru

Tempus Plans To Expand its Operations

Chicago-based healthcare startup, Tempus, secured $110 million after a Series E financing round, and has now hit the $2 billion valuation mark.

The company uses machine learning and genomic sequencing to better understand a patient’s tumor, and it tailors treatment plans best suited to combat it. It also uses next-gen sequencing, and artificial intelligence assisted image recognition to accelerate insights and helps thousands of physicians make data-driven decisions on behalf of their patients.

Founder, Eric Lefkofsky, who also founded Groupon, said the startup was in a period of “rapid growth and acceleration,” and the new investments will see them looking beyond oncology, with a new focus on other areas like cardiovascular disease and diabetes.

19 Top Healthcare Startup Competitions
Iolanda Bulgaru
Healthcare Weekly Staff

Iolanda is senior content strategist at Healthcare Weekly and has 30 years of experience in regulatory compliance, strategy and clinical psychology.

Leave a comment

Healthcare Weekly Newsletter

Get the latest in healthcare leadership, news, and innovation.

We don’t share your contact information with any 3rd party

Contact us

Get in touch to learn how we can help


Work Email


Thank you for contacting Healthcare Weekly.

We will get in touch with you shortly.